Breaking News

LabCorp Launches New COVID-19 Clinical Trial Site

To connect patients with US research trials; streamlining recruitment into studies to speed research

By: Contract Pharma

Contract Pharma Staff

LabCorp’s drug development business, Covance, has created COVID-19 Clinical Trial Connect in the U.S., a site designed to help people access information about how to participate in COVID-19 research. “Through COVID-19 Clinical Trial Connect, our goal is to link people interested in these clinical trials with sponsors so that together we may find solutions for this global pandemic,” said Michael Brooks, president, clinical development and commercialization solutions, Covance. “There are currentl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters